On July 12, 2019, ALJ Dee Lord issued a notice of Initial Determination on Violation in
Certain Microfluidic Systems, Components Thereof, and Products
Containing the Same (Inv. No. 337-TA-1100).
By way of background, this investigation is based on a January 11, 2018 complaint filed by 10X Genomics, Inc. alleging violation of Section 337 by Bio-Rad Laboratories, Inc. of Hercules, California for unlawfully importing into the U.S., selling for importation, and/or selling within the U.S. after importation certain microfluidic systems, components thereof, and products containing the same that infringe one or more claims of U.S. Patent Nos. 9,644,204 (the '204 patent), 9,689,024 (the '024 patent), 9,695,468 (the '468 patent), and 9,856,530 (the '530 patent).
According to the Notice, ALJ Lord determined, inter alia, that a violation of Section 337 has occurred with respect to the '024 patent, the '468 patent, and the '530 patent, but that no violation has occurred in connection with the '204 patent.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.